EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis

Johannes Piepgras, Marlene L Piepgras iD, Falk Steffen, Laura Ehrhardt, Martin A Schaller-Paule, Yavor Yalachkov, Frauke Zipp, Stefan Bittner iD

European Journal of Neurology · 2025-05 · 32 (5)

DOI: 10.1111/ene.70207 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2025-05-23. Written by Johannes Piepgras and 7 co-authors. Institution: Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University M…. Major MEDLINE topics: Glial Fibrillary Acidic Protein, Encephalitis, Neurofilament Proteins, Hashimoto Disease. Cited 9 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0). Funded by: Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft, Hermann und Lilly Schilling-Stiftung für Medizinische Forschung.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Management of autoimmune encephalitis (AE) is challenging due to a lack of reliable biomarkers. We here assess the combination of glial fibrillary acid protein (GFAP) and neurofilament (NfL) as biomarkers for diagnosis and disease monitoring of AE.

Methods

GFAP and NfL CSF levels (cGFAP, cNfL) of 42 AE patients were correlated with CSF markers of neuroinflammation. NfL/GFAP ratios were compared between patients with stable and active AE, stable and active multiple sclerosis (MS), and patients undergoing diagnostic lumbar puncture without evident pathological alterations (controls).

Results

In patients with AE, cGFAP levels showed strong correlations with albumin and IgG quotients and moderate correlations with CSF cell count; cNfL levels showed weak correlations with albumin quotients. cGFAP and cNfL levels showed no significant differences between patients with and without epileptic activity or inflammatory MRI lesions. Both sNfL and sGFAP correlated with the Clinical Assessment Scale in Autoimmune Encephalitis. Compared to NfL or GFAP alone, the NfL/GFAP ratio from CSF or serum led to a clearer separation of AE from MS patients and controls. Furthermore, serum NfL/GFAP ratios better discriminated active from stable AE. Conclusion cGFAP levels indicate intrathecal inflammatory processes in patients with active AE to a stronger degree than cNfL levels. Serum NfL/GFAP ratios recognize active AE, suggesting this ratio identifies AE patients with CNS‐compartmentalized neuronal injury (autoantibody‐mediated or cytotoxic) behind a relatively intact blood–brain barrier. Our findings indicate that the NfL/GFAP ratio can function as a blood‐based biomarker, aiding clinicians with diagnosis and disease management of AE.

Subjects

MeSH terms (MEDLINE)

Glial Fibrillary Acidic ProteinEncephalitisNeurofilament ProteinsHashimoto DiseaseHumansFemaleMaleAdultMiddle AgedBiomarkersYoung AdultAgedMultiple Sclerosis

Author keywords

autoimmune encephalitisbiomarkerglial fibrillary acid proteinneurofilamentneuroinflammation

Substances

Glial Fibrillary Acidic ProteinBiomarkersGFAP protein, humanNeurofilament Proteinsneurofilament protein L

Authors and institutions

  • Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germa…
  • Mainz, Germany.
  • Department of Pediatrics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Department of Neurology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

ORCID profiles: Marlene L Piepgras, Stefan Bittner

Funding

  • Else Kröner-Fresenius-Stiftung
  • Deutsche Forschungsgemeinschaft
  • Hermann und Lilly Schilling-Stiftung für Medizinische Forschung

Cite

APA

Piepgras, J., Piepgras, M. L., Steffen, F., Ehrhardt, L., Schaller-Paule, M. A., Yalachkov, Y., Zipp, F., & Bittner, S. (2025). Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis. European Journal of Neurology, 32(5). https://doi.org/10.1111/ene.70207

Vancouver

Piepgras J, Piepgras ML, Steffen F, Ehrhardt L, Schaller-Paule MA, Yalachkov Y, et al. Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis. European Journal of Neurology. 2025;32(5). doi:10.1111/ene.70207

BibTeX
@article{Piepgras2025,
  author = {Piepgras, Johannes and Piepgras, Marlene L and Steffen, Falk and Ehrhardt, Laura and Schaller-Paule, Martin A and Yalachkov, Yavor and Zipp, Frauke and Bittner, Stefan},
  title = {Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {5},
  doi = {10.1111/ene.70207}
}
Start for free →